Lisa Terranella

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial

Michael A. Nauck, Gary Meininger, Lisa Terranella et al. · Diabetes Obesity and Metabolism · 2007 · 667 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Finasteride in the treatment of men with frontal male pattern hair loss

James L. Leyden, Frank Dunlap, Bruce Miller et al. · Journal of the American Academy of Dermatology · 1999 · 244 citations

Medicine, Dermatology, Pharmacotherapy +6

Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss

Janet L. Roberts, Virginia C. Fiedler, Julianne Imperato‐McGinley et al. · Journal of the American Academy of Dermatology · 1999 · 110 citations

Medicine, Pharmacology, Pharmacotherapy +13

The effect of initial therapy with the fixed‐dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

Charles A. Reasner, Leann Olansky, Thomas Seck et al. · Diabetes Obesity and Metabolism · 2011 · 91 citations

Medicine, Pharmacology, Pharmacotherapy +17

A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

Leann Olansky, Charles A. Reasner, Thomas Seck et al. · Diabetes Obesity and Metabolism · 2011 · 49 citations

Medicine, Pharmacology, Pharmacotherapy +14